NCT00004092View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

Given IV or subcutaneously

DRUG

carboplatin

Given IV

DRUG

cyclophosphamide

Given IV

DRUG

doxorubicin hydrochloride

Given IV

DRUG

paclitaxel

Given IV

DRUG

thiotepa

Given IV

PROCEDURE

peripheral blood stem cell transplantation

Patients receive autologous peripheral blood stem cells

Trial Locations (2)

85006

Banner Good Samaritan Medical Center, Phoenix

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00004092 - Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer | Biotech Hunter | Biotech Hunter